Patient selection for thrombolytic therapy.
Recent studies have shown that the use of thrombolytic therapy in patients with acute myocardial infarction can reduce mortality 20 to 52%. However, patient selection issues remain to be resolved. These issues include the time window for therapy, treatment based on the site of infarction, treatment based on electrocardiographic criteria and treatment of the elderly population.